National Center for Cancer Immune Therapy,
Department of Oncology,
National Center for Cancer Immune Therapy, Department of Oncology
Cancer immunologist specialized in T cell biology, onco-immunology, and immunometabolism.
MERTK Acts as a Costimulatory Receptor on Human CD8 T Cells.
Cancer immunology research Sep, 2019 | Pubmed ID: 31266785
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Cancer immunology, immunotherapy : CII Feb, 2020 | Pubmed ID: 31664482
TAM Receptor Inhibition-Implications for Cancer and the Immune System.
Cancers Mar, 2021 | Pubmed ID: 33801886
University Hospital Herlev
Kasper Mølgaard*,1,
Anne Rahbech*,1,
Özcan Met1,
Inge Marie Svane1,
Per thor Straten1,3,
Claus Desler2,
Marlies J. W. Peeters1
1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev,
2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen,
3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
연구
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
교육
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
저자
사서
액세스
JoVE 소개
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. 판권 소유